These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6592359)
1. Synthesis and in vitro biological evaluation of N-[(5-amino-1-beta-D-ribofuranosyl-1H-imidazol-4-yl)carbonyl]-3- (hydroxynitrosamino)-L-alanine (L-alanosine AICO ribonucleoside). Strazzolini P; Malabarba A; Ferrari P; Grandi M; Cavalleri B J Med Chem; 1984 Oct; 27(10):1295-9. PubMed ID: 6592359 [TBL] [Abstract][Full Text] [Related]
2. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase. Tyagi AK; Cooney DA Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071 [TBL] [Abstract][Full Text] [Related]
3. Determinants of the toxicity of L-alanosine to various organs of the mouse. Tyagi AK; Thake DC; McGee E; Cooney DA Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196 [TBL] [Abstract][Full Text] [Related]
4. Nonenzymatic synthesis of 5-aminoimidazole ribonucleoside and recognition of its facile rearrangement. Groziak MP; Bhat B; Leonard NJ Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7174-6. PubMed ID: 3174626 [TBL] [Abstract][Full Text] [Related]
5. A novel synergistic effect of alanosine and guanine on adenine nucleotide synthesis in mammalian cells. Alanosine as a useful probe for investigating purine nucleotide metabolism. Gupta RS J Cell Physiol; 1980 Aug; 104(2):241-8. PubMed ID: 7410492 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of N6-(n-alkylureido)purine ribonucleosides and their 5'-phosphates. Hong CI; Mittelman A; Chheda GB J Pharm Sci; 1978 Apr; 67(4):569-71. PubMed ID: 565402 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3,4-d]pyrimidine ribonucleosides. Petrie CR; Cottam HB; McKernan PA; Robins RK; Revankar GR J Med Chem; 1985 Aug; 28(8):1010-6. PubMed ID: 4020823 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenylosuccinate lyase by L-alanosyl-5-aminoimidazole-4-carboxylic acid ribonucleotide (alanosyl-AICOR). Casey PJ; Lowenstein JM Biochem Pharmacol; 1987 Mar; 36(5):705-9. PubMed ID: 3827951 [TBL] [Abstract][Full Text] [Related]
9. Identification of gene expression profiles predicting tumor cell response to L-alanosine. Efferth T; Gebhart E; Ross DD; Sauerbrey A Biochem Pharmacol; 2003 Aug; 66(4):613-21. PubMed ID: 12906926 [TBL] [Abstract][Full Text] [Related]
10. Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells. Li W; Su D; Mizobuchi H; Martin DS; Gu B; Gorlick R; Cole P; Bertino JR Oncol Res; 2004; 14(7-8):373-9. PubMed ID: 15301428 [TBL] [Abstract][Full Text] [Related]
11. Synthesis properties of the naturally occurring N-[(9-beta-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt-6A) and other related synthetic analogs. Dutta SP; Hong CI; Murphy GP; Mittelman A; Chheda GB Biochemistry; 1975 Jul; 14(14):3144-51. PubMed ID: 1148194 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines. McNamara DJ; Cook PD J Med Chem; 1987 Feb; 30(2):340-7. PubMed ID: 3806615 [TBL] [Abstract][Full Text] [Related]
13. Pyrrolopyrimidine nucleosides. 18. Synthesis and chemotherapeutic activity of 4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (3'-deoxysangivamycin) and 4-amino-7-(2-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (2'-deoxysangivamycin). Maruyama T; Wotring LL; Townsend LB J Med Chem; 1983 Jan; 26(1):25-9. PubMed ID: 6827526 [TBL] [Abstract][Full Text] [Related]
14. 4-Amino-3-(2,3,5-tri-O-benzyl-beta-D-ribofuranosyl)-5-pyrazole-carb oni trile. Synthesis and conversion into a sugar-blocked 5,7-disubstituted formycin analog. Rosowsky A; Ghoshal M; Solan VC Carbohydr Res; 1988 May; 176(1):47-58. PubMed ID: 3401884 [TBL] [Abstract][Full Text] [Related]
15. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro. Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines related to formycin prepared via ring closure of a 1,2,4-triazine precursor. Ramasamy K; Ugarkar BG; McKernan PA; Robins RK; Revankar GR J Med Chem; 1986 Nov; 29(11):2231-5. PubMed ID: 3783585 [TBL] [Abstract][Full Text] [Related]
17. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate. Graff JC; Plagemann PG Cancer Res; 1976 Apr; 36(4):1428-40. PubMed ID: 177207 [TBL] [Abstract][Full Text] [Related]
19. A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer. Creagan ET; O'Connell MJ; Kovach JS Cancer; 1983 Aug; 52(4):615-8. PubMed ID: 6861099 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, cell growth inhibition, and antitumor screening of 2-(p-n-butylanilino)purines and their nucleoside analogues. Wright GE; Dudycz LW; Kazimierczuk Z; Brown NC; Khan NN J Med Chem; 1987 Jan; 30(1):109-16. PubMed ID: 3806587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]